Regencell bioscience holdings ltd RGC.US Overview Analysis
RGC AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has a low value rating. If your investment strategy is value-oriented and you have long-term positions, it's crucial to adhere to your exit plan and consider reducing holdings.
RGC Current Performance
72.65%
Regencell bioscience holdings ltd
0.38%
Avg of Sector
-0.07%
S&P500
Top 10 High Relevance to RGC
- WAI Top kingwin ltdValue -Trend 4Swing Trading 2Whale Interest -Dividend 1See more
RGC Profile
Regencell Bioscience Holdings Ltd. Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.